Acta neurologica Scandinavica
-
Acta Neurol. Scand. · May 2014
Comparative StudyIntravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
To compare intravenous phenytoin (PHT) and intravenous lacosamide (LCM) for treatment of status epilepticus after failure of the first and second drug. ⋯ Lacosamide and PHT showed similar success rates for treatment of SE when used after failure of benzodiazepines and levetiracetam. However, PHT was associated with relevant side effects that were not seen with LCM.